» Articles » PMID: 16041053

Similarity of Gene Expression Patterns in Human Alveolar Macrophages in Response to Pseudomonas Aeruginosa and Burkholderia Cepacia

Overview
Journal Infect Immun
Date 2005 Jul 26
PMID 16041053
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To determine if differences in the severity of pulmonary infection in cystic fibrosis seen with late isolates of Pseudomonas aeruginosa and Burkholderia cepacia are associated with differences in the initial response of alveolar macrophages (AM) to these pathogens, we assessed gene expression changes in human AM in response to infection with a laboratory strain, early and late clinical isolates of P. aeruginosa, and B. cepacia. Analysis of gene expression changes at the RNA level using oligonucleotide microarrays, following exposure to laboratory P. aeruginosa strain PAK, showed significant (P < 0.01) >2.5-fold upregulation of 42 genes and >2.5-fold downregulation of 45 genes. The majority of the changes in gene expression involved genes as part of inflammatory pathways and signaling systems. Interestingly, similar responses were observed following exposure of AM to early and late clinical isolates of P. aeruginosa, as well as with B. cepacia, suggesting that the more severe clinical outcome of infections with late clinical isolates of P. aeruginosa or with B. cepacia cannot be explained by differences in the early interactions of these organisms with the human AM, as reflected by the similarity of gene expression changes in response to exposure of AM to these pathogens.

Citing Articles

Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights.

Ideozu J, Zhang X, McColley S, Levy H Genes (Basel). 2019; 10(3).

PMID: 30813620 PMC: 6470978. DOI: 10.3390/genes10030180.


Mapping genetic determinants of host susceptibility to Pseudomonas aeruginosa lung infection in mice.

De Simone M, Spagnuolo L, Lore N, Cigana C, De Fino I, Broman K BMC Genomics. 2016; 17:351.

PMID: 27169516 PMC: 4866434. DOI: 10.1186/s12864-016-2676-4.


Analysis of Genome-scale Expression Network in Four Major Bacterial Residents of Cystic Fibrosis Lung.

Nazanin Hosseinkhan , Zarrineh P, Masoudi-Nejad A Curr Genomics. 2014; 15(5):408-18.

PMID: 25435803 PMC: 4245700. DOI: 10.2174/1389202915666140818205444.


Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Xu Y, Krause A, Hamai H, Harvey B, Worgall T, Worgall S PLoS One. 2010; 5(6):e11004.

PMID: 20543983 PMC: 2882373. DOI: 10.1371/journal.pone.0011004.


Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity.

Heurtault B, Gentine P, Thomann J, Baehr C, Frisch B, Pons F Pharm Res. 2008; 26(2):276-85.

PMID: 18781377 DOI: 10.1007/s11095-008-9724-y.

References
1.
Boucher R . An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev. 2002; 54(11):1359-71. DOI: 10.1016/s0169-409x(02)00144-8. View

2.
Dacheux D, Toussaint B, Richard M, Brochier G, Croize J, Attree I . Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect Immun. 2000; 68(5):2916-24. PMC: 97504. DOI: 10.1128/IAI.68.5.2916-2924.2000. View

3.
Su I, Basavaraj A, Krutchinsky A, Hobert O, Ullrich A, Chait B . Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol. 2002; 4(2):124-31. DOI: 10.1038/ni876. View

4.
Monick M, Hunninghake G . Second messenger pathways in pulmonary host defense. Annu Rev Physiol. 2003; 65:643-67. DOI: 10.1146/annurev.physiol.65.092101.142440. View

5.
Fujimoto J, Wiener-Kronish J, Hashimoto S, Sawa T . Effects of Cl2MDP-encapsulating liposomes in a murine model of Pseudomonas aeruginosa-induced sepsis. J Liposome Res. 2003; 12(3):239-57. DOI: 10.1081/lpr-120014760. View